Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 3
1(25.0%)
4Total
N/A(3)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04361994Recruiting

The GErman Italian Spanish Takotsubo (GEIST) Registry

Role: lead

NCT06804161Phase 3Recruiting

SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension

Role: lead

NCT06977139Recruiting

Interventional Structural Registry - LuEbeck

Role: lead

NCT06804148Recruiting

MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry

Role: lead

NCT05204212Not ApplicableRecruiting

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

Role: lead

NCT04558723Not ApplicableRecruiting

Cardiac Magnetic Resonance Guidance of Implantable Cardioverter Defibrillator Implantation in Non-ischemic Dilated Cardiomyopathy

Role: lead

NCT04301921Not ApplicableUnknown

Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography - Diagnostic Transradial Coronary Angiography Without Systemic Anticoagulatio

Role: lead

All 7 trials loaded